The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing ...

The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders, such as Candel Therapeutic ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

Kazia Therapeutics , an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, ...

Cell division is a fundamental process that allows cells to replicate accurately and maintain tissue homeostasis. This ...

Detailed price information for Biovaxys Technology Corp (BVAXF) from The Globe and Mail including charting and trades.

This repository contains a modular, reproducible pipeline for predicting cell cycle phases (G1, S, G2M) from single-cell RNA-seq data using deep learning and traditional machine learning models.

Background: The adult mammalian heart exhibits limited regenerative capability, primarily due to the postnatal arrest of the cardiomyocyte (CM) cell cycle. Aim: To elucidate the role of checkpoint ...

Shenzhen Key Laboratory of Viral Oncology, Department of Science and Innovation, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong 518100, P. R. China Shenzhen School of Clinical ...

New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint ...